PL3869195T3 - Ulepszone testy potencjału oddziaływania ludzkich komórek nabłonka barwnikowego siatkówki (RPE) i fotoreceptorów progenitorowych - Google Patents
Ulepszone testy potencjału oddziaływania ludzkich komórek nabłonka barwnikowego siatkówki (RPE) i fotoreceptorów progenitorowychInfo
- Publication number
- PL3869195T3 PL3869195T3 PL21167900.6T PL21167900T PL3869195T3 PL 3869195 T3 PL3869195 T3 PL 3869195T3 PL 21167900 T PL21167900 T PL 21167900T PL 3869195 T3 PL3869195 T3 PL 3869195T3
- Authority
- PL
- Poland
- Prior art keywords
- rpe
- potency
- cells
- retinal pigment
- pigment epithelium
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/16—Ophthalmology
- G01N2800/164—Retinal disorders, e.g. retinopathy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562136660P | 2015-03-23 | 2015-03-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3869195T3 true PL3869195T3 (pl) | 2024-07-22 |
Family
ID=55752717
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16716342T PL3274710T3 (pl) | 2015-03-23 | 2016-03-23 | Ulepszone testy do oznaczania potencjału ludzkich komórek nabłonka barwnikowego siatkówki (rpe) i komórek progenitorowych fotoreceptorów |
| PL21167900.6T PL3869195T3 (pl) | 2015-03-23 | 2016-03-23 | Ulepszone testy potencjału oddziaływania ludzkich komórek nabłonka barwnikowego siatkówki (RPE) i fotoreceptorów progenitorowych |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16716342T PL3274710T3 (pl) | 2015-03-23 | 2016-03-23 | Ulepszone testy do oznaczania potencjału ludzkich komórek nabłonka barwnikowego siatkówki (rpe) i komórek progenitorowych fotoreceptorów |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US11422125B2 (pl) |
| EP (3) | EP3274710B1 (pl) |
| JP (4) | JP6902474B2 (pl) |
| KR (2) | KR102577776B1 (pl) |
| CN (3) | CN118995872A (pl) |
| AU (3) | AU2016235176B2 (pl) |
| CA (2) | CA2980580C (pl) |
| DK (1) | DK3274710T3 (pl) |
| ES (2) | ES2980659T3 (pl) |
| HU (1) | HUE054946T2 (pl) |
| IL (3) | IL303401A (pl) |
| MX (2) | MX395233B (pl) |
| PL (2) | PL3274710T3 (pl) |
| PT (2) | PT3274710T (pl) |
| SG (3) | SG11201707775TA (pl) |
| WO (1) | WO2016154357A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2596119B8 (en) | 2010-07-23 | 2021-06-02 | Astellas Institute for Regenerative Medicine | Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
| ES2980659T3 (es) * | 2015-03-23 | 2024-10-02 | Astellas Inst For Regenerative Medicine | Ensayos mejorados de potencia de células de epitelio pigmentario retiniano (EPR) humano y progenitores de fotorreceptores |
| SG10201913250SA (en) | 2015-08-18 | 2020-03-30 | Astellas Inst For Regenerative Medicine | Clinical formulations |
| WO2021086911A1 (en) | 2019-10-30 | 2021-05-06 | Astellas Institute For Regenerative Medicine | Methods for producing retinal pigment epithelium cells |
| KR102452657B1 (ko) * | 2020-09-09 | 2022-10-11 | 조선대학교 산학협력단 | Noxa 단백질에서 유래한 펩타이드를 포함하는 세포외 소포 생산 촉진용 조성물 및 이를 이용한 세포외 소포의 생산 방법 |
| DE102022103893A1 (de) * | 2022-02-18 | 2023-08-24 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein | Membranvesikel, die einen spektroskopisch nachweisbaren Indikator beinhalten, und deren Verwendung in einem Verfahren zum Nachweis der Phagozytose-Funktion bei biologischen Zellen |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6432711B1 (en) | 1993-11-03 | 2002-08-13 | Diacrin, Inc. | Embryonic stem cells capable of differentiating into desired cell lines |
| CN1362965A (zh) | 1999-06-30 | 2002-08-07 | 先进细胞技术公司 | 细胞质转移使受体细胞去分化 |
| US20040199935A1 (en) | 1999-06-30 | 2004-10-07 | Chapman Karen B. | Cytoplasmic transfer to de-differentiate recipient cells |
| US20110171185A1 (en) | 1999-06-30 | 2011-07-14 | Klimanskaya Irina V | Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof |
| US20050255596A1 (en) | 1999-09-07 | 2005-11-17 | West Michael D | Methods of repairing tandemly repeated DNA sequences and extending cell life-span nuclear transfer |
| NZ531844A (en) | 1999-09-07 | 2005-08-26 | Advanced Cell Tech Inc | Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| US20040180430A1 (en) | 1999-09-07 | 2004-09-16 | West Michael D. | Methods of restoring telomere length and extending cell lifespan using nuclear transfer |
| CA2388510A1 (en) | 1999-11-02 | 2001-05-10 | James M. Robl | Use of haploid genomes for genetic diagnosis, modification and multiplication |
| AU784731B2 (en) | 1999-12-20 | 2006-06-08 | University Of Massachusetts | Embryonic or stem-like cells produced by cross species nuclear transplantation |
| AU2279301A (en) | 1999-12-20 | 2001-07-03 | Peter Mombaerts | A method to produce cloned embryos and adults from cultured cells |
| AU2002258477A1 (en) | 2001-03-08 | 2002-09-24 | Advanced Cell Technology, Inc. | Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| WO2002073188A1 (en) | 2001-03-13 | 2002-09-19 | Advanced Cell Technology, Inc. | Method for generating replacement cells and/or tissues |
| CA2458575C (en) | 2001-08-24 | 2014-07-08 | Advanced Cell Technology, Inc. | Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy |
| WO2004060056A2 (en) | 2002-12-27 | 2004-07-22 | Advanced Cell Technology, Inc. | Sperm-induced cellular activation |
| EP1711594A4 (en) | 2004-01-02 | 2007-07-11 | Advanced Cell Tech Inc | NEW CULTURAL SYSTEMS FOR EX-VIVO DEVELOPMENT |
| US20190282622A1 (en) | 2004-01-23 | 2019-09-19 | Astellas Institute For Regenerative Medicine | Modalities for the treatment of degenerative diseases of the retina |
| BRPI0507074A (pt) | 2004-01-23 | 2007-06-19 | Advanced Cell Tech Inc | modalidades aperfeiçoadas para o tratamento de doenças degenerativas da retina |
| US7794704B2 (en) | 2004-01-23 | 2010-09-14 | Advanced Cell Technology, Inc. | Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration |
| GB0407836D0 (en) | 2004-04-06 | 2004-05-12 | Univ Cambridge Tech | Fluorescent dyes and complexes |
| US7893315B2 (en) | 2004-11-04 | 2011-02-22 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells and embryo-derived cells |
| CA3015835A1 (en) | 2004-11-04 | 2006-05-18 | Astellas Institute For Regenerative Medicine | Derivation of embryonic stem cells |
| US20060263338A1 (en) | 2005-03-04 | 2006-11-23 | Jacoby Douglas B | Catheter-based delivery of Skeletal Myoblasts to the Myocardium of Damaged Hearts |
| WO2006122005A2 (en) | 2005-05-09 | 2006-11-16 | Mytogen, Inc. | Cellular cardiomyoplasty as supportive therapy in patients with heart disease |
| EP2302034B1 (en) | 2005-08-03 | 2020-10-14 | Astellas Institute for Regenerative Medicine | Improved methods of reprogramming animal somatic cells |
| WO2007047894A2 (en) | 2005-10-20 | 2007-04-26 | Advanced Cell Technology, Inc. | Totipotent, nearly totipotent or pluripotent mammalian cells homozygous or hemizygous for one or more histocompatibility antigen genes |
| EP2029724A4 (en) | 2006-05-03 | 2010-03-24 | Advanced Cell Tech Inc | DERIVATION FROM EMBRYONAL STEM CELLS AND EMBRYO-DERIVED CELLS |
| JP2010518857A (ja) | 2007-02-23 | 2010-06-03 | アドバンスド セル テクノロジー， インコーポレイテッド | 分化した細胞の再プログラムおよび再プログラムされた細胞からの動物および胚幹細胞の生成のための高能率的な方法 |
| IL292561A (en) | 2007-10-12 | 2022-06-01 | Astellas Inst For Regenerative Medicine | Improved methods of rpe cell production and rpe cell preparations |
| WO2009085212A1 (en) | 2007-12-19 | 2009-07-09 | Advanced Cell Technology, Inc. | Methods for producing pluripotent stem cell-generated embryos, and animals derived therefrom |
| US10485829B2 (en) | 2009-11-17 | 2019-11-26 | Astellas Institute For Regenerative Medicine | Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells |
| EP2596119B8 (en) | 2010-07-23 | 2021-06-02 | Astellas Institute for Regenerative Medicine | Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
| US20120184035A1 (en) | 2011-01-13 | 2012-07-19 | Sadhana Agarwal | Methods and Compositions For Reprogramming Cells |
| TWI719277B (zh) | 2011-11-14 | 2021-02-21 | 美商安斯泰來再生醫藥協會 | 人類rpe細胞之醫藥組合物及其用途 |
| US8961956B2 (en) | 2011-11-30 | 2015-02-24 | Ocata Therapeutics, Inc. | Mesenchymal stromal cells and uses related thereto |
| KR102246369B1 (ko) | 2011-11-30 | 2021-04-29 | 아스텔라스 인스티튜트 포 리제너러티브 메디슨 | 중간엽 간질 세포 및 이에 관련된 용도 |
| LT2788472T (lt) | 2011-12-06 | 2019-04-10 | Astellas Institute For Regenerative Medicine | Kryptingos diferenciacijos būdas, skirtas ragenos endotelio ląstelių gamybai |
| US9511152B2 (en) | 2012-04-05 | 2016-12-06 | The Board Of Regents Of The University Of Texas System | Multicolored pH-activatable fluorescence nanoplatform |
| CA3177929A1 (en) | 2012-12-21 | 2014-06-26 | Astellas Institute For Regenerative Medicine | Methods for production of platelets from pluripotent stem cells and compositions thereof |
| US20160175362A1 (en) | 2014-03-14 | 2016-06-23 | Ocata Therapeutics, Inc. | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells |
| US11241460B2 (en) | 2013-03-15 | 2022-02-08 | Astellas Institute For Regenerative Medicine | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells |
| KR20230058556A (ko) | 2013-03-15 | 2023-05-03 | 아스텔라스 인스티튜트 포 리제너러티브 메디슨 | 만능 줄기 세포로부터 제조된 광수용기 및 광수용기 전구체 |
| US20160175361A1 (en) | 2014-03-14 | 2016-06-23 | Advanced Cell Technology, Inc. | Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells |
| WO2016037159A1 (en) | 2014-09-05 | 2016-03-10 | Ocata Therapeutics, Inc. | Retinal ganglion cells and progenitors thereof |
| ES2980659T3 (es) | 2015-03-23 | 2024-10-02 | Astellas Inst For Regenerative Medicine | Ensayos mejorados de potencia de células de epitelio pigmentario retiniano (EPR) humano y progenitores de fotorreceptores |
| SG10201913250SA (en) | 2015-08-18 | 2020-03-30 | Astellas Inst For Regenerative Medicine | Clinical formulations |
-
2016
- 2016-03-23 ES ES21167900T patent/ES2980659T3/es active Active
- 2016-03-23 EP EP16716342.7A patent/EP3274710B1/en active Active
- 2016-03-23 US US15/560,584 patent/US11422125B2/en active Active
- 2016-03-23 EP EP24154934.4A patent/EP4343331A3/en active Pending
- 2016-03-23 PT PT167163427T patent/PT3274710T/pt unknown
- 2016-03-23 EP EP21167900.6A patent/EP3869195B1/en active Active
- 2016-03-23 CN CN202411118882.1A patent/CN118995872A/zh active Pending
- 2016-03-23 PL PL16716342T patent/PL3274710T3/pl unknown
- 2016-03-23 ES ES16716342T patent/ES2877400T3/es active Active
- 2016-03-23 CN CN201680029779.7A patent/CN107889507B/zh active Active
- 2016-03-23 CA CA2980580A patent/CA2980580C/en active Active
- 2016-03-23 PT PT211679006T patent/PT3869195T/pt unknown
- 2016-03-23 SG SG11201707775TA patent/SG11201707775TA/en unknown
- 2016-03-23 JP JP2017550191A patent/JP6902474B2/ja active Active
- 2016-03-23 KR KR1020177030540A patent/KR102577776B1/ko active Active
- 2016-03-23 IL IL303401A patent/IL303401A/en unknown
- 2016-03-23 IL IL293110A patent/IL293110B2/en unknown
- 2016-03-23 SG SG10201912315UA patent/SG10201912315UA/en unknown
- 2016-03-23 CN CN202111336261.7A patent/CN113930476B/zh active Active
- 2016-03-23 DK DK16716342.7T patent/DK3274710T3/da active
- 2016-03-23 MX MX2017012259A patent/MX395233B/es unknown
- 2016-03-23 WO PCT/US2016/023839 patent/WO2016154357A1/en not_active Ceased
- 2016-03-23 PL PL21167900.6T patent/PL3869195T3/pl unknown
- 2016-03-23 SG SG10201907918V patent/SG10201907918VA/en unknown
- 2016-03-23 KR KR1020237030529A patent/KR20230132893A/ko active Pending
- 2016-03-23 AU AU2016235176A patent/AU2016235176B2/en active Active
- 2016-03-23 HU HUE16716342A patent/HUE054946T2/hu unknown
- 2016-03-23 CA CA3188112A patent/CA3188112A1/en active Pending
-
2017
- 2017-09-24 IL IL254617A patent/IL254617B/en unknown
- 2017-09-25 MX MX2022010736A patent/MX2022010736A/es unknown
-
2021
- 2021-06-21 JP JP2021102569A patent/JP7386206B2/ja active Active
-
2022
- 2022-08-15 US US17/887,783 patent/US11680941B2/en active Active
- 2022-08-17 AU AU2022218516A patent/AU2022218516B2/en active Active
-
2023
- 2023-05-12 US US18/316,785 patent/US20230408489A1/en active Pending
- 2023-11-13 JP JP2023192860A patent/JP2024037720A/ja active Pending
-
2025
- 2025-08-01 JP JP2025129163A patent/JP2025183199A/ja active Pending
- 2025-09-05 AU AU2025226799A patent/AU2025226799A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL254617B (en) | Improved assays for the potential of retinal pigment epithelium (rpe) cells and photoreceptor progenitors | |
| IL258824B (en) | Preparation of pigmented epithelial retinal cells | |
| EP3177732A4 (en) | Compositions and methods for the treatment of ophthalmic diseases and conditions | |
| EP3624773A4 (en) | OPHTHALMIC COMPOSITIONS AND METHOD OF USE | |
| EP3096617A4 (en) | Compositions and methods for treating ocular diseases | |
| PL3331994T3 (pl) | Wytwarzanie komórek nabłonka barwnikowego siatkówki | |
| EP3240612A4 (en) | Methods of treating retinal diseases | |
| EP3164058A4 (en) | Systems and methods for alignment of the eye for ocular imaging | |
| IL268357A (en) | Photoreceptor cells for the treatment of retinal diseases | |
| EP3265096A4 (en) | Ophthalmic compositions and methods of use therefor | |
| EP3238736A4 (en) | Peptide for treating ocular diseases and composition for treating ocular diseases comprising same | |
| EP3672523A4 (en) | ONE-PIECE INTRAOCULAR LENSES AND METHOD OF MANUFACTURING THEREOF | |
| EP3189135A4 (en) | Retinal ganglion cells and progenitors thereof | |
| EP3464635A4 (en) | TYPES OF TYPES OF HUMAN LEUCOCYTARY ANTIGEN | |
| EP3213762A4 (en) | Novel treatment of cornea using laminin | |
| EP3286563A4 (en) | Controlled induction of human pancreatic progenitors produces functional beta-like cells | |
| EP3213761A4 (en) | Novel treatment of retina and nerve using laminin | |
| EP3193867A4 (en) | Ocular formulations for drug-delivery and protection of the anterior segment of the eye | |
| EP3634438A4 (en) | COMPOSITIONS FOR THE TREATMENT OF NETWORK DISEASES AND METHOD FOR THEIR MANUFACTURE AND USE | |
| EP3464566A4 (en) | SELECTION OF HUMAN HEMATOPOETIC STEM CELLS USING EPCR | |
| EP3265103A4 (en) | Compositions and methods for treating ocular diseases | |
| EP3154637A4 (en) | Treatment of virus-based diseases of the skin | |
| EP3496833A4 (en) | ARRANGEMENT OF A CHILD'S HOUSE FOR PRE-SCHOOL LEARNING IN SPONGE | |
| EP3261652A4 (en) | Extract of taiwanese propolis for treating ocular diseases | |
| EP3601374A4 (en) | REFINED BETA GLUCANS AND METHODS FOR MANUFACTURING THE SAME |